Emmaus Life Sciences, Inc. Quarterly report pursuant to Section 13 or 15(d)

SELECTED FINANCIAL STATEMENT CAPTIONS - ASSETS

3 Months Ended

Mar. 31, 2021

NOTE 4 — SELECTED FINANCIAL STATEMENT CAPTIONS - ASSETS

Inventories consisted of the following (in thousands):

	March 31, 2021			December 31, 2020
Raw materials and components	$	1,486		$	1,486
Work-in-process		690			721
Finished goods		5,913			6,064
Inventory reserve		(1,349	)		(1,184	)
Total	$	6,740		$	7,087

Prepaid expenses and other current assets consisted of the following (in thousands):

Property and equipment consisted of the following (in thousands):

	March 31, 2021			December 31, 2020
Equipment	$	331		$	347
Leasehold improvements		39			39
Furniture and fixtures		99			99
Total property and equipment		469			485
Less: accumulated depreciation		(360	)		(365	)
Property and Equipment, net	$	109		$	120

During the three months ended March 31, 2021 and March 31, 2020, depreciation expense was approximately $11,000 and $12,000, respectively.